The current role of partial surgery as a strategy for functional preservation in laryngeal carcinoma;El papel actual de la cirugía parcial como estrategia de preservación funcional en el carcinoma de laringe

Acta Otorrinolaringologica Espanola

Volumn 62, Issue 3, 2011, Pages 231-238

  Rodrigo, Juan Pablo ^a   Coca Pelaz, Andrés ^a   Suárez, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cancer; Laryngectomy; Larynx; Organ preservation

Indexed keywords

CANCER SURGERY; CLINICAL PROTOCOL; HUMAN; LARYNGECTOMY; LARYNX; LARYNX CARCINOMA; LASER SURGERY; MINIMALLY INVASIVE SURGERY; ORGAN PRESERVATION; SHORT SURVEY; SURGICAL TECHNIQUE;

ALGORITHMS; APHONIA; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNGOSCOPY; LASER THERAPY; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; ROBOTICS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955634122     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otorri.2010.06.002     Document Type: Short Survey

References (53)

1. Johnson J.T., Hao S., Myers E.N., Wagner R.L. Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol 1993, 102:752-755.
2. Thomas J.V., Olsen K.D., Neel H.B., DeSanto L.W., Suman V.J. Early glottic carcinoma treated with open laryngeal procedures. Arch Otolaryngol Head Neck Surg 1994, 120:264-268.
3. Brumund K.T., Gutierrez-Fonseca R., Garcia D., Babin E., Hans S., Laccourreye O. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 2005, 114:314-322.
4. Kessler D.J., Trapp T.K., Calcaterra T.C. The treatment of T3 glottic carcinoma with vertical partial laryngectomy. Arch Otolaryngol Head Neck Surg 1987, 113:1196-1199.
5. Biller H.F., Lawson W. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord. Laryngoscope 1986, 96:61-64.
6. Laccourreye O., Laccourreye L., Garcia D., Gutierrez-Fonseca R., Brasnu D., Weinstein G. Vertical Partial Laryngectomy versus Supracricoid Partial Laryngectomy for Selected Carcinomas of the True Vocal Cord Classified as T2N0. Ann Otol Rhinol Laryngol 2000, 109:965-971.
7. Karatzanis A.D., Psychogios G., Zenk J., Waldfahrer F., Hornung J., Velegrakis G.A., et al. Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope 2009, 119:1704-1708.
8. Alonso J.M. Conservative surgery of cancer of the larynx. Trans Am Acad Ophthalmol Otolaryngol 1947, 51:633-642.
9. Ogura J.H. Supraglottic Subtotal Laryngectomy and Radical Neck Dissection for Carcinoma of the Epiglottis. Laryngoscope 1958, 68:983-1003.
10. Myers E.N., Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996, 106:559-567.
11. Sevilla M.A., Rodrigo J.P., Llorente J.L., Cabanillas R., López F., Suárez C. Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 2008, 265:11-16.
12. Scola B., Fernandez-Vega M., Martinez T., Fernandez-Vega S., Ramirez C. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001, 124:195-198.
13. Herranz J., Martinez Vidal J., Martinez Moran A. Supraglottic laryngectomy. Still on-going. Acta Otorrinolaringol Esp 2006, 57:235-241.
14. Herranz González-Botas J., Gavilan Bouzas J., Martínez Vidal J. Laringuectomía supraglótica: resultados a 3 y 5 años. Acta Otorrinolaringol Esp 1999, 50:269-275.
15. Robbins K.T., Davidson W., Peters L.J., Goepfert H. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 1988, 114:421-426.
16. Sessions D.G., Lenox J., Spector G.J. Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 2005, 115:1402-1410.
17. Prades J.M., Simon P.G., Timoshenko A.P., Dumollard J.M., Schmitt T., Martin C. Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol 2005, 262:947-952.
18. Suárez C., Rodrigo J.P., Herranz J., Llorente J.L., Martínez J.A. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol 1995, 104:358-363.
19. Rodrigo J.P., Suárez C., Silver C.E., Rinaldo A., Ambrosch P., Fagan J.J., et al. Transoral laser surgery for supraglottic cancer. Head Neck 2008, 30:658-666.
20. Majer H., Rieder A. Technique de laryngectomie permettant de conserver la perméabilité respiratoire: la crico-hyoïdopexie. Ann Otolaryngol Chir Cervicofac 1959, 76:677-683.
21. Schwaab G., Kolb F., Julieron M., Janot F, Le Ridant AM, Mamelle G, et al. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997). Eur Arch Otorhinolaryngol 2001, 258:246-249.
22. De Vincentiis M., Minni A., Gallo A., Di Nardo A Supracricoid partial laryngectomies: oncological and functional results. Head Neck 1998, 20:504-509.
23. Laccourreye O., Brasnu D., Perie S., Muscatello L, Ménard M, Weinstein G. Supracricoid partial laryngectomies in the elderly: mortality, complications, and functional outcome. Laryngoscope 1998, 108:237-242.
24. Laccourreye O., Brasnu D., Biacabe B., Hans S, Seckin S, Weinstein G. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 1998, 20:595-599.
25. Laccourreye O., Muscatello L., Laccourreye L., Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with crocohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2-N0 invading the anterior commissure. Am J Otolaryngol 1997, 18:385-390.
26. Brasnu D.F. Supracricoid Partial Laryngectomy with Cricohyoidopexy in the Management of Laryngeal Carcinoma. World J Surg 2003, 27:817-823.
27. Laccourreye O., Crevier Buchman L., Weinstein G.S., Biacabe B, Laccourreye H, Brasnu D. Duration and frequency characteristics of speech and voice following supracricoid partial laryngectomy. Ann Otol Rhinol Laryngol 1995, 104:516-521.
28. Naudo P., Laccourreye O., Weinstein G.S., Hans S, Laccourreye H, Brasnu D. Functional outcome and pronostic factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol 1997, 106:291-296.
29. Peretti G, Piazza C, Cocco D, De Benedetto L, Del Bon F, Redaelli De Zinis LO, et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: The University of Brescia experience on 595 patients. Head Neck 2009 Nov 9. [Epub ahead of print].
30. Vilaseca I, Bernal-Sprekelsen M, Luis Blanch J. Transoral laser microsurgery for T3 laryngeal tumors: Prognostic factors. Head Neck 2009 Dec 1. [Epub ahead of print].
31. Hinni M.L., Salassa J.R., Grant D.G., Pearson B.W., Hayden R.E., Martin A., et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007, 133:1198-1204.
32. Rudert H.H., Werner J.A., Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 1999, 108:819-827.
33. Motta G., Esposito E., Testa D., Iovine R., Motta S. CO2 laser treatment of supraglottic cancer. Head Neck 2004, 26:442-446.
34. Cabanillas R., Rodrigo J.P., Llorente J.L., Suárez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 2008, 30:750-755.
35. Blanch J.L., Vilaseca I., Bernal-Sprekelsen M., Grau J.J., Moragas M., Traserra-Coderch J., et al. Prognostic significance of surgical margins in transoral CO(2) laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol 2007, 264:1045-1051.
36. Roh J.L., Kim D.H., Park C.I. Voice, swallowing and quality of life in patients after transoral laser surgery for supraglottic carcinoma. J Surg Oncol 2008, 98:184-189.
37. Cabanillas R., Rodrigo J.P., Llorente J.L., Suárez V., Ortega P., Suárez C. Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 2004, 26:653-659.
38. Peretti G., Piazza C., Cattaneo A., De Benedetto L., Martin E., Nicolai P. Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol 2006, 115:827-832.
39. Weinstein G.S., O'Malley B.W., Hockstein N.G. Transoral robotic surgery: supraglottic laryngectomy in a canine model. Laryngoscope 2005, 115:1315-1319.
40. O'Malley B.W., Weinstein G.S., Hockstein N.G. Transoral robotic surgery (TORS): glottic microsurgery in a canine model. J Voice 2006, 20:263-268.
41. Desai S.C., Sung C.K., Jang D.W., Genden E.M. Transoral robotic surgery using a carbon dioxide flexible laser for tumors of the upper aerodigestive tract. Laryngoscope 2008, 118:2187-2189.
42. Genden E.M., Desai S., Sung C.K. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck 2009, 31:283-289.
43. Iseli T.A., Kulbersh B.D., Iseli C.E., Carroll W.R., Rosenthal E.L., Magnuson J.S. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg 2009, 141:166-171.
44. Forastiere A.A., Goepfert H., Maor M., Pajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098.
45. Adelstein D.J., Lavertu P., Saxton J.P., Secic M., Wood B.G., Wanamaker J.R., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000, 88:876-883.
46. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial-EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890-899.
47. Pignon J.P., Bourhis J., Domenge C., Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three metaanalyses of updated individual data-MACH-NC Collaborative Group: Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000, 355:949-955.
48. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal Cancer. N Engl J Med 1991, 324:1685-1690. The Department of Veterans Affairs Laryngeal Cancer Study Group.
49. Hoffman H.T., Porter K., Karnell L.H., Cooper J.S., Weber R.S., Langer C.J., et al. Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival. Laryngoscope 2006, 116(Suppl. 111):1-13.
50. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics 2004. CA Cancer J Clin 2004, 54:8-29. American Cancer Society.
51. NCCN practice guidelines in oncology. Head and neck cancers. V.1.2009. Disponible en: http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf.
52. Pfister D.G., Laurie S.A., Weinstein G.S., Mendenhall W.M., Adelstein D.J., Ang K.K., et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006, 24:3693-3704.
53. Weinstein GS, Laccourreye O. Organ preservation surgery of the larynx: A new paradigm. En: Weinstein GS, Laccourreye O, Brasnu D, Laccourreye H, editores. Organ preservation surgery for laryngeal cancer. San Diego: Singular Publishing Group; 1999. p. 5.